Patents by Inventor Adam SCHAYOWITZ

Adam SCHAYOWITZ has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9766249
    Abstract: The present invention is based on the discovery that functional stratification and/or signaling profiles can be used for diagnosing disease status, determining drug resistance or sensitivity of cancer cells, monitoring a disease or responsiveness to a therapeutic agent, and/or predicting a therapeutic outcome for a subject. Provided herein are assays for diagnosis and/or prognosis of diseases in patients. Also provided are compositions and methods that evaluate the resistance or sensitivity of diseases to targeted therapeutic agents prior to initiation of the therapeutic regimen and to monitor the therapeutic effects of the therapeutic regimen. Also provided are methods for determining the difference between a basal level or state of a molecule in a sample and the level or state of the molecule after stimulation of a portion of the live sample with a modulator ex vivo, wherein the difference is expressed as a value which is indicative of the presence, absence or risk of having a disease.
    Type: Grant
    Filed: April 18, 2011
    Date of Patent: September 19, 2017
    Assignee: BioMarker Strategies, LLC
    Inventors: Douglas P. Clark, Adam Schayowitz, Cirilo D. Cabradilla
  • Publication number: 20150353880
    Abstract: Embodiments of the present invention are directed to improved methods and devices for analyzing a cell, aggregated cells, or a solid tumor. Such methods and devices are, for example, useful in the field of pathology and can provide improved cell processing and analytical results.
    Type: Application
    Filed: August 20, 2015
    Publication date: December 10, 2015
    Inventors: Douglas P. Clark, Adam Schayowitz, Kathleen M. Murphy, Scott Diamond
  • Patent number: 9121801
    Abstract: Embodiments of the present invention are directed to improved methods and devices for analyzing a cell, aggregated cells, or a solid tumor. Such methods and devices are, for example, useful in the field of pathology and can provide improved cell processing and analytical results.
    Type: Grant
    Filed: October 24, 2008
    Date of Patent: September 1, 2015
    Assignee: BioMarker Strategies, LLC
    Inventors: Douglas P. Clark, Adam Schayowitz, Kathleen M. Murphy, Scott Diamond
  • Publication number: 20120094853
    Abstract: The present invention is based on the discovery that functional stratification and/or signaling profiles can be used for diagnosing disease status, determining drug resistance or sensitivity of cancer cells, monitoring a disease or responsiveness to a therapeutic agent, and/or predicting a therapeutic outcome for a subject. Provided herein are assays for diagnosis and/or prognosis of diseases in patients. Also provided are compositions and methods that evaluate the resistance or sensitivity of diseases to targeted therapeutic agents prior to initiation of the therapeutic regimen and to monitor the therapeutic effects of the therapeutic regimen. Also provided are methods for determining the difference between a basal level or state of a molecule in a sample and the level or state of the molecule after stimulation of a portion of the live sample with a modulator ex vivo, wherein the difference is expressed as a value which is indicative of the presence, absence or risk of having a disease.
    Type: Application
    Filed: April 18, 2011
    Publication date: April 19, 2012
    Applicant: BIOMARKER STRATEGIES, LLC.
    Inventors: Douglas P. Clark, Adam Schayowitz, Cirilo D. Cabradilla
  • Publication number: 20090162853
    Abstract: Embodiments of the present invention are directed to improved methods and devices for analyzing a cell, aggregated cells, or a solid tumor. Such methods and devices are, for example, useful in the field of pathology and can provide improved cell processing and analytical results.
    Type: Application
    Filed: October 24, 2008
    Publication date: June 25, 2009
    Applicant: BioMarker Strategies, LLC
    Inventors: Douglas P. CLARK, Adam SCHAYOWITZ, Kathleen M. MURPHY, Scott DIAMOND